Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1987 Jun;68(3):580–587.

Growth hormone treatment stimulates thymulin production in aged dogs.

B L Goff 1, J A Roth 1, L H Arp 1, G S Incefy 1
PMCID: PMC1542764  PMID: 3652525

Abstract

Diminished thymic morphology and function and a decreased provocative growth hormone (GH) response are characteristic of normal ageing. We have previously demonstrated that bovine growth hormone (bGH) treatment of adult dogs tends to result in a rejuvenation of thymic morphology. The purpose of this study was twofold: (1) to determine concentrations of thymulin (a thymic hormone) in plasma from dogs of various ages, and (2) to evaluate the effect of bGH administration on plasma thymulin concentration and thymus morphology in 'middle-aged' and 'old-aged' dogs. 'Young' (4 months), 'middle-aged' (33-55 months) and 'old-aged' (63-83 months) female beagles served as subjects for this study. Middle- and old-aged dogs were injected with either bGH or bovine serum albumin (control) for 1 month. Thymulin concentration in plasma was determined by the rosette-inhibition bioassay. An age-associated decline in the plasma concentration of thymulin was detected. Plasma thymulin concentration increased in every bGH-treated dog. In middle-aged but not old-aged dogs, bGH treatment resulted in rejuvenation of thymic morphological features as determined by stereological and histomorphological procedures. The results suggest that exogenous GH may be useful for restoration of some immune functions in aged individuals.

Full text

PDF
580

Images in this article

583Fig. 2
on p.583

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Atkinson K., Incefy G. S., Storb R., Sullivan K. M., Iwata T., Dardenne M., Ochs H. D., Good R. A., Thomas E. D. Low serum thymic hormone levels in patients with chronic graft-versus-host disease. Blood. 1982 May;59(5):1073–1077. [PubMed] [Google Scholar]
  2. Bach J. F., Dardenne M., Pleau J. M., Bach M. A. Isolation, biochemical characteristics, and biological activity of a circulating thymic hormone in the mouse and in the human. Ann N Y Acad Sci. 1975 Feb 28;249:186–210. doi: 10.1111/j.1749-6632.1975.tb29068.x. [DOI] [PubMed] [Google Scholar]
  3. Bach M. A., Beaurain G. Respective influence of extrinsic and intrinsic factors on the age-related decrease of thymic secretion. J Immunol. 1979 Jun;122(6):2505–2507. [PubMed] [Google Scholar]
  4. Bach M. A. Lymphocyte-mediated cytotoxicity: effects of ageing, adult thymectomy and thymic factor. J Immunol. 1977 Aug;119(2):641–647. [PubMed] [Google Scholar]
  5. Bene M. C., Faure G., Bordigoni P., Olive D., Duheille J. In vitro induction of monoclonal antibody-defined T-cell markers in lymphocytes from immunodeficient children by synthetic serum thymic factor (FTS). Clin Exp Immunol. 1982 May;48(2):423–428. [PMC free article] [PubMed] [Google Scholar]
  6. Chandra R. K., Heresi G., Au B. Serum thymic factor activity in deficiencies of calories, zinc, vitamin A and pyridoxine. Clin Exp Immunol. 1980 Nov;42(2):332–335. [PMC free article] [PubMed] [Google Scholar]
  7. Delafuente J. C. Immunosenescence. Clinical and pharmacologic considerations. Med Clin North Am. 1985 May;69(3):475–486. doi: 10.1016/s0025-7125(16)31027-6. [DOI] [PubMed] [Google Scholar]
  8. Elias H., Hennig A., Schwartz D. E. Stereology: applications to biomedicalresearch. Physiol Rev. 1971 Jan;51(1):158–200. doi: 10.1152/physrev.1971.51.1.158. [DOI] [PubMed] [Google Scholar]
  9. Fabris N., Mocchegiani E. Endocrine control of thymic serum factor production in young-adult and old mice. Cell Immunol. 1985 Apr 1;91(2):325–335. doi: 10.1016/0008-8749(85)90230-8. [DOI] [PubMed] [Google Scholar]
  10. Fabris N., Mocchegiani E., Mariotti S., Pacini F., Pinchera A. Thyroid function modulates thymic endocrine activity. J Clin Endocrinol Metab. 1986 Mar;62(3):474–478. doi: 10.1210/jcem-62-3-474. [DOI] [PubMed] [Google Scholar]
  11. Fabris N., Muzzioli M., Mocchegiani E. Recovery of age-dependent immunological deterioration in Balb/c mice by short-term treatment with L-thyroxine. Mech Ageing Dev. 1982 Apr;18(4):327–338. doi: 10.1016/0047-6374(82)90036-7. [DOI] [PubMed] [Google Scholar]
  12. Faure G., Bene M. C., Tamisier J. N., Gaucher A., Duheille J. Thymulin (FTS-Zn) induced in vitro modulation of T cell subsets markers on lymphocytes from rheumatoid arthritis and systemic lupus erythematosus patients. Int J Immunopharmacol. 1984;6(4):381–388. doi: 10.1016/0192-0561(84)90058-4. [DOI] [PubMed] [Google Scholar]
  13. Franceschi C., Licastro F., Chiricolo M., Bonetti F., Zannotti M., Fabris N., Mocchegiani E., Fantini M. P., Paolucci P., Masi M. Deficiency of autologous mixed lymphocyte reactions and serum thymic factor level in Down's syndrome. J Immunol. 1981 Jun;126(6):2161–2164. [PubMed] [Google Scholar]
  14. Garaci E., Ronchetti R., Del Gobbo V., Tramutoli G., Rinaldi-Garaci C., Imperato C. Decreased serum thymic factor activity in asthmatic children. J Allergy Clin Immunol. 1978 Dec;62(6):357–362. doi: 10.1016/0091-6749(78)90136-7. [DOI] [PubMed] [Google Scholar]
  15. Grody W. W., Fligiel S., Naeim F. Thymus involution in the acquired immunodeficiency syndrome. Am J Clin Pathol. 1985 Jul;84(1):85–95. doi: 10.1093/ajcp/84.1.85. [DOI] [PubMed] [Google Scholar]
  16. Hall N. R., Goldstein A. L. The thymus-brain connection: interactions between thymosin and the neuroendocrine system. Lymphokine Res. 1983;2(1):1–6. [PubMed] [Google Scholar]
  17. Incefy G. S., Pahwa S., Pahwa R., Sarngadharan M. G., Menez R., Fikrig S. Low circulating thymulin-like activity in children with AIDS and AIDS-related complex. AIDS Res. 1986 Spring;2(2):109–116. doi: 10.1089/aid.1.1986.2.109. [DOI] [PubMed] [Google Scholar]
  18. Iwata T., Incefy G. S., Cunningham-Rundles S., Cunningham-Rundles C., Smithwick E., Geller N., O'Reilly R., Good R. A. Circulating thymic hormone activity in patients with primary and secondary immunodeficiency diseases. Am J Med. 1981 Sep;71(3):385–394. doi: 10.1016/0002-9343(81)90164-9. [DOI] [PubMed] [Google Scholar]
  19. Kelley K. W., Brief S., Westly H. J., Novakofski J., Bechtel P. J., Simon J., Walker E. B. GH3 pituitary adenoma cells can reverse thymic aging in rats. Proc Natl Acad Sci U S A. 1986 Aug;83(15):5663–5667. doi: 10.1073/pnas.83.15.5663. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Loud A. V., Anversa P. Morphometric analysis of biologic processes. Lab Invest. 1984 Mar;50(3):250–261. [PubMed] [Google Scholar]
  21. Martial J. A., Baxter J. D., Goodman H. M., Seeburg P. H. Regulation of growth hormone messenger RNA by thyroid and glucocorticoid hormones. Proc Natl Acad Sci U S A. 1977 May;74(5):1816–1820. doi: 10.1073/pnas.74.5.1816. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Ohga K., Incefy G. S., Wang C. Y., Good R. A. Generation of a monoclonal antibody against facteur thymique serique (FTS). Clin Exp Immunol. 1982 Mar;47(3):725–734. [PMC free article] [PubMed] [Google Scholar]
  23. Peake G. T., Birge C. A., Daughaday W. H. Alterations of radioimmunoassayable growth hormone and prolactin during hypothroidism. Endocrinology. 1973 Feb;92(2):487–493. doi: 10.1210/endo-92-2-487. [DOI] [PubMed] [Google Scholar]
  24. Savino W., Dardenne M., Bach J. F. Thymic hormone containing cells. III. Evidence for a feed-back regulation of the secretion of the serum thymic factor (FTS) by thymic epithelial cells. Clin Exp Immunol. 1983 Apr;52(1):7–12. [PMC free article] [PubMed] [Google Scholar]
  25. Schulof R. S. Thymic peptide hormones: basic properties and clinical applications in cancer. Crit Rev Oncol Hematol. 1985;3(4):309–376. doi: 10.1016/s1040-8428(85)80035-4. [DOI] [PubMed] [Google Scholar]
  26. Schuurman H. J., Van de Wijngaert F. P., Delvoye L., Broekhuizen R., McClure J. E., Goldstein A. L., Kater L. Heterogeneity and age dependency of human thymus reticulo-epithelium in production of thymosin components. Thymus. 1985;7(1):13–23. [PubMed] [Google Scholar]
  27. Steinmann G. G., Klaus B., Müller-Hermelink H. K. The involution of the ageing human thymic epithelium is independent of puberty. A morphometric study. Scand J Immunol. 1985 Nov;22(5):563–575. doi: 10.1111/j.1365-3083.1985.tb01916.x. [DOI] [PubMed] [Google Scholar]
  28. Wade S., Bleiberg F., Mossé A., Lubetzki J., Flavigny H., Chapuis P., Roche D., Lemonnier D., Dardenne M. Thymulin (Zn-facteur thymique serique) activity in anorexia nervosa patients. Am J Clin Nutr. 1985 Aug;42(2):275–280. doi: 10.1093/ajcn/42.2.275. [DOI] [PubMed] [Google Scholar]
  29. Zatz M. M., Goldstein A. L. Thymosins, lymphokines, and the immunology of aging. Gerontology. 1985;31(4):263–277. doi: 10.1159/000212709. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES